-
Citi Downgrades R1 RCM Inc (RCM) to Neutral
-
Jefferies Downgrades R1 RCM Inc (RCM) to Hold
-
R1 RCM agrees to be taken private by Towerbook, CD&R for $8.9 billion; shares jump
-
R1 RCM (RCM) August 11 and 12.5 puts active into TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R), purchasing
-
R1 RCM (RCM) to be Acquired by TowerBrook and CD&R for $8.9 Billion, $14.30 Per Share
-
R1 RCM (RCM) Halted, News Pending
-
R1 RCM (RCM) Special Committee Provides Update on Evaluation of Strategic Alternatives
-
RBC Capital Reiterates Outperform Rating on R1 RCM Inc (RCM)
-
TD Cowen Reiterates Buy Rating on R1 RCM Inc (RCM)
-
RCM stock surges as TCP-ASC updates takeover proposal
-
R1 RCM (RCM) gains as TCP-ASC finalizing takeover offer
-
TD Cowen Reiterates Buy Rating on R1 RCM Inc (RCM)
-
R1 RCM (RCM) sinks 10% as New Mountain Capital lowers offer, no longer intersted in joint deal with TCP-ASC
-
RBC Capital Reiterates Outperform Rating on R1 RCM Inc (RCM)
-
R1 RCM (RCM) grants waiver request to joint takeover group
-
TD Cowen Reiterates Buy Rating on R1 RCM Inc (RCM)
-
RBC Capital Reiterates Outperform Rating on R1 RCM Inc (RCM)
-
Here's why this stock is Morgan Stanley's top healthcare technology pick

